Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine
Clinical trial NCT04962893 · COMPLETED
Trial details
- NCT number
- NCT04962893
- Sponsor
- Ihsan GURSEL, PhD, Prof.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-26
- Primary completion
- 2022-01-16
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.